Innegligible Musculoskeletal Disorders Caused by Zoledronic Acid in Adjuvant Breast Cancer Treatment: A Meta-Analysis

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/1756-9966-30-72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Adjuvant Zoledronic Acid Reduces Fractures in Breast Cancer Patients; An AZURE (BIG 01/04) Study

European Journal of Cancer
Cancer ResearchOncology
2018English

Adjuvant Bisphosphonates in Breast Cancer Treatment

Breast Care
SurgeryOncology
2014English

Taxanes in Adjuvant Breast Cancer Treatment

Libri Oncologici
Oncology
2018English

Zoledronic Acid Inhibits Macrophage/Microglia-Assisted Breast Cancer Cell Invasion

Oncotarget
Oncology
2013English

Metformin as an Adjuvant in Breast Cancer Treatment

SAGE Open Medicine
Medicine
2019English

Adjuvant Drug Treatment for Resectable Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Adjuvant Treatment for Breast Cancer: The Overview.

BMJ
1992English

Adjuvant Treatment With Polyadenylic-Polyuridylic Acid in Operable Breast Cancer: Updated Results of a Randomised Trial.

BMJ
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy